Požymis
Chest pain
An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) localized to the chest.
Santrauka
- Taip pat vadinama
- Thoracic pain
- Kūno sistema
- Constitutional symptom
Atskaitos genomasGRCh38hg38
Pozicijos genų ir variantų puslapiuose rodomos pagal šį pasirinkimą šioje naršyklėje.
Read the genes linked to Chest pain, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test143 genų susiję su Chest pain
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Chest pain. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| EMDemerin | Visada | 1 ligoje |
| POPDC2popeye domain cAMP effector 2 | Visada | 1 ligoje |
| SOX17SRY-box transcription factor 17 | Visada | 1 ligoje |
| CALRcalreticulin | Labai dažnai (80–99%) | 1 ligoje |
| JAK2Janus kinase 2 | Labai dažnai (80–99%) | 2 ligose |
| MPLMPL proto-oncogene, thrombopoietin receptor | Labai dažnai (80–99%) | 2 ligose |
| SH2B3SH2B adaptor protein 3 | Labai dažnai (80–99%) | 1 ligoje |
| TET2tet methylcytosine dioxygenase 2 | Labai dažnai (80–99%) | 1 ligoje |
| TP53tumor protein p53 | Labai dažnai (80–99%) | 1 ligoje |
| TSC1TSC complex subunit 1 | Labai dažnai (80–99%) | 1 ligoje |
| TSC2TSC complex subunit 2 | Labai dažnai (80–99%) | 1 ligoje |
| ABCC9ATP binding cassette subfamily C member 9 | Dažnai (30–79%) | 1 ligoje |
| ACTA2actin alpha 2, smooth muscle | Dažnai (30–79%) | 1 ligoje |
| BAP1BRCA1 associated deubiquitinase 1 | Dažnai (30–79%) | 1 ligoje |
| BTNL2butyrophilin like 2 | Dažnai (30–79%) | 2 ligose |
| CDH2cadherin 2 | Dažnai (30–79%) | 1 ligoje |
| CFTRCF transmembrane conductance regulator | Dažnai (30–79%) | 1 ligoje |
| COL3A1collagen type III alpha 1 chain | Dažnai (30–79%) | 1 ligoje |
| COL4A5collagen type IV alpha 5 chain | Dažnai (30–79%) | 1 ligoje |
| COL4A6collagen type IV alpha 6 chain | Dažnai (30–79%) | 1 ligoje |
| CRLF1cytokine receptor like factor 1 | Dažnai (30–79%) | 1 ligoje |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Dažnai (30–79%) | 1 ligoje |
| DLEC1DLEC1 cilia and flagella associated protein | Dažnai (30–79%) | 1 ligoje |
| DLSTdihydrolipoamide S-succinyltransferase | Dažnai (30–79%) | 1 ligoje |
| DNMT3ADNA methyltransferase 3 alpha | Dažnai (30–79%) | 1 ligoje |
| DPM3dolichyl-phosphate mannosyltransferase subunit 3, regulatory | Dažnai (30–79%) | 1 ligoje |
| EFEMP2EGF-like fibulin extracellular matrix protein 2 | Dažnai (30–79%) | 1 ligoje |
| ELNelastin | Dažnai (30–79%) | 1 ligoje |
| EPAS1endothelial PAS domain protein 1 | Dažnai (30–79%) | 1 ligoje |
| ERBB2erb-b2 receptor tyrosine kinase 2 | Dažnai (30–79%) | 1 ligoje |
| FBN1fibrillin 1 | Dažnai (30–79%) | 1 ligoje |
| FHfumarate hydratase | Dažnai (30–79%) | 1 ligoje |
| FOXE3forkhead box E3 | Dažnai (30–79%) | 1 ligoje |
| GATA4GATA binding protein 4 | Dažnai (30–79%) | 1 ligoje |
| GATA5GATA binding protein 5 | Dažnai (30–79%) | 1 ligoje |
| GATA6GATA binding protein 6 | Dažnai (30–79%) | 1 ligoje |
| GJA5gap junction protein alpha 5 | Dažnai (30–79%) | 1 ligoje |
| HBBhemoglobin subunit beta | Dažnai (30–79%) | 1 ligoje |
| HEY2hes related family bHLH transcription factor with YRPW motif 2 | Dažnai (30–79%) | 1 ligoje |
| HLA-Bmajor histocompatibility complex, class I, B | Dažnai (30–79%) | 1 ligoje |
Rodyti dar 103 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Dažnai (30–79%) | 1 ligoje |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Dažnai (30–79%) | 1 ligoje |
| HLA-DQA1major histocompatibility complex, class II, DQ alpha 1 | Dažnai (30–79%) | 1 ligoje |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Dažnai (30–79%) | 1 ligoje |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Dažnai (30–79%) | 3 ligose |
| IL12Binterleukin 12B | Dažnai (30–79%) | 1 ligoje |
| KCNA5potassium voltage-gated channel subfamily A member 5 | Dažnai (30–79%) | 1 ligoje |
| KCNE1potassium voltage-gated channel subfamily E regulatory subunit 1 | Dažnai (30–79%) | 1 ligoje |
| KCNE2potassium voltage-gated channel subfamily E regulatory subunit 2 | Dažnai (30–79%) | 1 ligoje |
| KCNJ2potassium inwardly rectifying channel subfamily J member 2 | Dažnai (30–79%) | 1 ligoje |
| KCNJ3potassium inwardly rectifying channel subfamily J member 3 | Dažnai (30–79%) | 1 ligoje |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Dažnai (30–79%) | 1 ligoje |
| KCNQ1potassium voltage-gated channel subfamily Q member 1 | Dažnai (30–79%) | 1 ligoje |
| KIF1Bkinesin family member 1B | Dažnai (30–79%) | 1 ligoje |
| LAMP2lysosome associated membrane protein 2 | Dažnai (30–79%) | 1 ligoje |
| LOXlysyl oxidase | Dažnai (30–79%) | 1 ligoje |
| MAT2Amethionine adenosyltransferase 2A | Dažnai (30–79%) | 1 ligoje |
| MAXMYC associated transcriptional regulator X | Dažnai (30–79%) | 1 ligoje |
| MDH2malate dehydrogenase 2 | Dažnai (30–79%) | 1 ligoje |
| MEFVMEFV innate immunity regulator, pyrin | Dažnai (30–79%) | 3 ligose |
| MFAP5microfibril associated protein 5 | Dažnai (30–79%) | 1 ligoje |
| MLXMAX dimerization protein MLX | Dažnai (30–79%) | 1 ligoje |
| MYH11myosin heavy chain 11 | Dažnai (30–79%) | 2 ligose |
| MYH7myosin heavy chain 7 | Dažnai (30–79%) | 1 ligoje |
| MYL4myosin light chain 4 | Dažnai (30–79%) | 1 ligoje |
| MYLKmyosin light chain kinase | Dažnai (30–79%) | 1 ligoje |
| NF1neurofibromin 1 | Dažnai (30–79%) | 1 ligoje |
| NKX2-5NK2 homeobox 5 | Dažnai (30–79%) | 1 ligoje |
| NKX2-6NK2 homeobox 6 | Dažnai (30–79%) | 1 ligoje |
| NOS1nitric oxide synthase 1 | Dažnai (30–79%) | 1 ligoje |
| NPPAnatriuretic peptide A | Dažnai (30–79%) | 1 ligoje |
| NUP155nucleoporin 155 | Dažnai (30–79%) | 1 ligoje |
| PIGAphosphatidylinositol glycan anchor biosynthesis class A | Dažnai (30–79%) | 1 ligoje |
| PITX2paired like homeodomain 2 | Dažnai (30–79%) | 1 ligoje |
| PPOXprotoporphyrinogen oxidase | Dažnai (30–79%) | 1 ligoje |
| PRKG1protein kinase cGMP-dependent 1 | Dažnai (30–79%) | 1 ligoje |
| PRTN3proteinase 3 | Dažnai (30–79%) | 1 ligoje |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Dažnai (30–79%) | 1 ligoje |
| RETret proto-oncogene | Dažnai (30–79%) | 3 ligose |
| RNF6ring finger protein 6 | Dažnai (30–79%) | 1 ligoje |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Dažnai (30–79%) | 1 ligoje |
| SCN2Bsodium voltage-gated channel beta subunit 2 | Dažnai (30–79%) | 1 ligoje |
| SCN3Bsodium voltage-gated channel beta subunit 3 | Dažnai (30–79%) | 1 ligoje |
| SCN4Asodium voltage-gated channel alpha subunit 4 | Dažnai (30–79%) | 3 ligose |
| SCN4Bsodium voltage-gated channel beta subunit 4 | Dažnai (30–79%) | 1 ligoje |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Dažnai (30–79%) | 1 ligoje |
| SCNN1Asodium channel epithelial 1 subunit alpha | Dažnai (30–79%) | 1 ligoje |
| SCNN1Bsodium channel epithelial 1 subunit beta | Dažnai (30–79%) | 1 ligoje |
| SCNN1Gsodium channel epithelial 1 subunit gamma | Dažnai (30–79%) | 1 ligoje |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Dažnai (30–79%) | 1 ligoje |
| SDHAF2succinate dehydrogenase complex assembly factor 2 | Dažnai (30–79%) | 1 ligoje |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Dažnai (30–79%) | 2 ligose |
| SDHCsuccinate dehydrogenase complex subunit C | Dažnai (30–79%) | 1 ligoje |
| SDHDsuccinate dehydrogenase complex subunit D | Dažnai (30–79%) | 2 ligose |
| SLC25A11solute carrier family 25 member 11 | Dažnai (30–79%) | 1 ligoje |
| SLC34A2solute carrier family 34 member 2 | Dažnai (30–79%) | 1 ligoje |
| SMAD2SMAD family member 2 | Dažnai (30–79%) | 1 ligoje |
| SMAD3SMAD family member 3 | Dažnai (30–79%) | 1 ligoje |
| SMAD4SMAD family member 4 | Dažnai (30–79%) | 1 ligoje |
| TGFB2transforming growth factor beta 2 | Dažnai (30–79%) | 1 ligoje |
| TGFB3transforming growth factor beta 3 | Dažnai (30–79%) | 1 ligoje |
| TGFBR1transforming growth factor beta receptor 1 | Dažnai (30–79%) | 1 ligoje |
| TGFBR2transforming growth factor beta receptor 2 | Dažnai (30–79%) | 2 ligose |
| THPOthrombopoietin | Dažnai (30–79%) | 1 ligoje |
| THSD4thrombospondin type 1 domain containing 4 | Dažnai (30–79%) | 1 ligoje |
| TMEM127transmembrane protein 127 | Dažnai (30–79%) | 1 ligoje |
| TTNtitin | Dažnai (30–79%) | 1 ligoje |
| VHLvon Hippel-Lindau tumor suppressor | Dažnai (30–79%) | 2 ligose |
| WWOXWW domain containing oxidoreductase | Dažnai (30–79%) | 1 ligoje |
| ACTC1actin alpha cardiac muscle 1 | Kartais (5–29%) | 1 ligoje |
| ADAMTS19ADAM metallopeptidase with thrombospondin type 1 motif 19 | Kartais (5–29%) | 1 ligoje |
| APCAPC regulator of Wnt signaling pathway | Kartais (5–29%) | 1 ligoje |
| CAV3caveolin 3 | Kartais (5–29%) | 1 ligoje |
| CD4CD4 molecule | Kartais (5–29%) | 1 ligoje |
| CTNNB1catenin beta 1 | Kartais (5–29%) | 1 ligoje |
| DBHdopamine beta-hydroxylase | Kartais (5–29%) | 1 ligoje |
| DSG2desmoglein 2 | Kartais (5–29%) | 1 ligoje |
| GNASGNAS complex locus | Kartais (5–29%) | 3 ligose |
| IRF4interferon regulatory factor 4 | Kartais (5–29%) | 1 ligoje |
| MT-TKmitochondrially encoded tRNA-Lys (AAA/G) | Kartais (5–29%) | 1 ligoje |
| MYL2myosin light chain 2 | Kartais (5–29%) | 1 ligoje |
| NDC1NDC1 transmembrane nucleoporin | Kartais (5–29%) | 1 ligoje |
| NOD2nucleotide binding oligomerization domain containing 2 | Kartais (5–29%) | 1 ligoje |
| PRKAG2protein kinase AMP-activated non-catalytic subunit gamma 2 | Kartais (5–29%) | 1 ligoje |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Kartais (5–29%) | 1 ligoje |
| RASA1RAS p21 protein activator 1 | Kartais (5–29%) | 1 ligoje |
| STAT3signal transducer and activator of transcription 3 | Kartais (5–29%) | 1 ligoje |
| STX16syntaxin 16 | Kartais (5–29%) | 1 ligoje |
| TNFRSF1ATNF receptor superfamily member 1A | Kartais (5–29%) | 1 ligoje |
| WASWASP actin nucleation promoting factor | Kartais (5–29%) | 1 ligoje |
| EXT1exostosin glycosyltransferase 1 | Retai (1–4 %) | 1 ligoje |
| EXT2exostosin glycosyltransferase 2 | Retai (1–4 %) | 1 ligoje |
| IRAK1interleukin 1 receptor associated kinase 1 | Retai (1–4 %) | 1 ligoje |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Retai (1–4 %) | 1 ligoje |
| SPP1secreted phosphoprotein 1 | Retai (1–4 %) | 1 ligoje |
| STAT4signal transducer and activator of transcription 4 | Retai (1–4 %) | 1 ligoje |
| ENGendoglin | Neužfiksuota | 1 ligoje |
| MEF2Amyocyte enhancer factor 2A | Neužfiksuota | 1 ligoje |
| MYBPC3myosin binding protein C3 | Neužfiksuota | 1 ligoje |
| PLNphospholamban | Neužfiksuota | 1 ligoje |
| PPA2inorganic pyrophosphatase 2 | Neužfiksuota | 1 ligoje |
| TMEM43transmembrane protein 43 | Neužfiksuota | 1 ligoje |
| TNNC1troponin C1, slow skeletal and cardiac type | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites